|
OMIM |
Link |
Information gain |
01 |
|
ehlers-danlos syndrome, type vib
|
[NCBI]
|
0.00425215
|
|
|
bruck syndrome 1
|
[NCBI]
|
0.00425102
|
|
|
alport syndrome, autosomal dominant
|
[NCBI]
|
0.00373915
|
|
|
ehlers-danlos syndrome, type viii
|
[NCBI]
|
0.00341076
|
|
|
spondyloepiphyseal dysplasia tarda, autosomal dominant
|
[NCBI]
|
0.00341076
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
0.0028865
|
|
|
dyssegmental dysplasia, rolland-desbuquois type
|
[NCBI]
|
0.00282989
|
|
|
acetabular dysplasia
|
[NCBI]
|
0.00282989
|
|
|
hip dysplasia, beukes type
|
[NCBI]
|
0.00282989
|
|
|
RA
|
[NCBI]
|
0.00252469
|
|
|
VRNI
|
[NCBI]
|
0.00231283
|
|
|
aneurysm, intracranial berry, 1
|
[NCBI]
|
0.00214147
|
|
|
storage pool platelet disease
|
[NCBI]
|
0.00188851
|
|
|
ehlers-danlos syndrome, type v
|
[NCBI]
|
0.00180111
|
|
|
osteogenesis imperfecta, type iia
|
[NCBI]
|
0.00147994
|
|
|
MVP
|
[NCBI]
|
0.0014239
|
|
|
collagenosis, familial reactive perforating
|
[NCBI]
|
0.0014129
|
|
|
CNA1
|
[NCBI]
|
0.0014129
|
|
|
larsen-like syndrome
|
[NCBI]
|
0.0014129
|
|
|
larsen syndrome, recessive
|
[NCBI]
|
0.0014129
|
|
|
doughnut lesions of skull, familial
|
[NCBI]
|
0.0014129
|
|
|
spondylodysplasia with pure brachyolmia
|
[NCBI]
|
0.0014129
|
|
|
aortic aneurysm, familial thoracic 1
|
[NCBI]
|
0.0014129
|
|
|
dupuytren contracture
|
[NCBI]
|
0.0014129
|
|
|
hydroxylysinuria
|
[NCBI]
|
0.0014129
|
|
|
opsismodysplasia
|
[NCBI]
|
0.0014129
|
|
|
COL1A1
|
[NCBI]
|
0.00138195
|
|
|
scleroderma, familial progressive
|
[NCBI]
|
0.00132195
|
|
|
COL1A2
|
[NCBI]
|
0.00124395
|
|
|
ATS
|
[NCBI]
|
0.00113407
|
|
|
IS1
|
[NCBI]
|
0.00111095
|
|
|
COL2A1
|
[NCBI]
|
0.000995152
|
|
|
STL1
|
[NCBI]
|
0.000979038
|
|
|
CF
|
[NCBI]
|
0.000917639
|
|
|
COL7A1
|
[NCBI]
|
0.000912078
|
|
|
ehlers-danlos syndrome, type vii, autosomal recessive
|
[NCBI]
|
0.000911145
|
|
|
ehlers-danlos syndrome, type i
|
[NCBI]
|
0.000911145
|
|
|
CMDR
|
[NCBI]
|
0.000898607
|
|
|
AKE
|
[NCBI]
|
0.000898607
|
|
|
thrombasthenia-thrombocytopenia, hereditary
|
[NCBI]
|
0.000898607
|
|
|
SEDC
|
[NCBI]
|
0.00089118
|
|
|
ehlers-danlos syndrome, type iv, autosomal dominant
|
[NCBI]
|
0.000798589
|
|
|
EXT3
|
[NCBI]
|
0.000710097
|
|
|
progeroid syndrome, neonatal
|
[NCBI]
|
0.000710097
|
|
|
scott syndrome
|
[NCBI]
|
0.000679178
|
|
|
SLE
|
[NCBI]
|
0.00067887
|
|
|
kniest dysplasia
|
[NCBI]
|
0.000636272
|
|
|
ehlers-danlos syndrome, type vi
|
[NCBI]
|
0.000614754
|
|
|
cutis laxa, corneal clouding, and mental retardation
|
[NCBI]
|
0.000590836
|
|
|
NNO1
|
[NCBI]
|
0.000590836
|
|
|
COL10A1
|
[NCBI]
|
0.000590813
|
|
|
leiomyomatosis, esophageal and vulval, with nephropathy
|
[NCBI]
|
0.000586505
|
|
|
CTGF
|
[NCBI]
|
0.000557869
|
|
|
COL4A5
|
[NCBI]
|
0.000551124
|
|
|
alport syndrome, autosomal recessive
|
[NCBI]
|
0.000521398
|
|
|
ehlers-danlos syndrome, type ii
|
[NCBI]
|
0.000521398
|
|
|
COL4A3
|
[NCBI]
|
0.000518738
|
|
|
ehlers-danlos syndrome, type vii, autosomal dominant
|
[NCBI]
|
0.000500182
|
|
|
COL3A1
|
[NCBI]
|
0.000495365
|
|
|
COL17A1
|
[NCBI]
|
0.000494815
|
|
|
GABEB
|
[NCBI]
|
0.00049096
|
|
|
ACG2
|
[NCBI]
|
0.000484615
|
|
|
SDC2
|
[NCBI]
|
0.000454717
|
|
|
GPS
|
[NCBI]
|
0.000452322
|
|
|
spondyloepiphyseal dysplasia tarda, toledo type
|
[NCBI]
|
0.000437468
|
|
|
epidermolysis bullosa dystrophica, pasini type
|
[NCBI]
|
0.000434392
|
|
|
TBDN
|
[NCBI]
|
0.000427398
|
|
|
PSACH
|
[NCBI]
|
0.000419352
|
|
|
osteogenesis imperfecta, type iii
|
[NCBI]
|
0.00040316
|
|
|
EDM3
|
[NCBI]
|
0.0003909
|
|
|
WDM
|
[NCBI]
|
0.000383272
|
|
|
PTH
|
[NCBI]
|
0.000377875
|
|
|
OSMED
|
[NCBI]
|
0.000369025
|
|
|
COL5A1
|
[NCBI]
|
0.000359291
|
|
|
stiff skin syndrome
|
[NCBI]
|
0.000338176
|
|
|
EDM2
|
[NCBI]
|
0.000334198
|
|
|
spondyloepimetaphyseal dysplasia, strudwick type
|
[NCBI]
|
0.000334198
|
|
|
marshall syndrome
|
[NCBI]
|
0.000334198
|
|
|
MCDS
|
[NCBI]
|
0.000332303
|
|
|
VEGF
|
[NCBI]
|
0.000331408
|
|
|
COMP
|
[NCBI]
|
0.000320192
|
|
|
STL2
|
[NCBI]
|
0.000304498
|
|
|
COL6A1
|
[NCBI]
|
0.000304492
|
|
|
COL15A1
|
[NCBI]
|
0.000303379
|
|
|
glaucoma-related pigment dispersion syndrome
|
[NCBI]
|
0.000299884
|
|
|
CRC
|
[NCBI]
|
0.000297798
|
|
|
osteoporosis
|
[NCBI]
|
0.000297761
|
|
|
HGF
|
[NCBI]
|
0.000295806
|
|
|
COL11A2
|
[NCBI]
|
0.000295574
|
|
|
DFSP
|
[NCBI]
|
0.000287843
|
|
|
bethlem myopathy
|
[NCBI]
|
0.000283582
|
|
|
MFS
|
[NCBI]
|
0.000282862
|
|
|
EGF
|
[NCBI]
|
0.000274105
|
|
|
COL9A1
|
[NCBI]
|
0.000263328
|
|
|
COL4A4
|
[NCBI]
|
0.000259701
|
|
|
DST
|
[NCBI]
|
0.000258376
|
|
|
osteogenesis imperfecta, type iv
|
[NCBI]
|
0.000257771
|
|
|
COL18A1
|
[NCBI]
|
0.00024847
|
|
|
EBDSC
|
[NCBI]
|
0.000242192
|
|
|
SPP1
|
[NCBI]
|
0.000226901
|
|
|
COL11A1
|
[NCBI]
|
0.00022511
|
|
|
STL3
|
[NCBI]
|
0.000217082
|
|
|
epidermolysis bullosa pruriginosa
|
[NCBI]
|
0.000217082
|
|
|
COL4A1
|
[NCBI]
|
0.000211313
|
|
|
COL4A6
|
[NCBI]
|
0.000202217
|
|
|
epstein syndrome
|
[NCBI]
|
0.000199307
|
|
|
bruck syndrome 2
|
[NCBI]
|
0.000195398
|
|
|
epidermolysis bullosa, pretibial
|
[NCBI]
|
0.000195398
|
|
|
epidermolysis bullosa with congenital localized absence of skin and deformity of nails
|
[NCBI]
|
0.000195398
|
|
|
ehlers-danlos syndrome, autosomal recessive, cardiac valvular form
|
[NCBI]
|
0.000195398
|
|
|
alpha-2-deficient collagen disease
|
[NCBI]
|
0.000195398
|
|
|
LSA
|
[NCBI]
|
0.000192433
|
|
|
EAD
|
[NCBI]
|
0.000185459
|
|
|
NPY
|
[NCBI]
|
0.000183028
|
|
|
PTK2
|
[NCBI]
|
0.000178229
|
|
|
AVP
|
[NCBI]
|
0.000178042
|
|
|
tight skin contracture syndrome, lethal
|
[NCBI]
|
0.000174103
|
|
|
COL5A2
|
[NCBI]
|
0.000167846
|
|
|
PDP
|
[NCBI]
|
0.000164479
|
|
|
COL9A3
|
[NCBI]
|
0.00016084
|
|
|
CCK
|
[NCBI]
|
0.00015753
|
|
|
toenail dystrophy, isolated
|
[NCBI]
|
0.000152198
|
|
|
cardiomyopathy-hypogonadism-collagenoma syndrome
|
[NCBI]
|
0.000152198
|
|
|
KNO
|
[NCBI]
|
0.000152198
|
|
|
COLQ
|
[NCBI]
|
0.000151499
|
|
|
SPARC
|
[NCBI]
|
0.00014841
|
|
|
BGLAP
|
[NCBI]
|
0.000145049
|
|
|
TH
|
[NCBI]
|
0.000138855
|
|
|
COL4A2
|
[NCBI]
|
0.000136325
|
|
|
diastrophic dysplasia
|
[NCBI]
|
0.000136249
|
|
|
COL6A3
|
[NCBI]
|
0.000129173
|
|
|
COL14A1
|
[NCBI]
|
0.000126369
|
|
|
PRL
|
[NCBI]
|
0.000124504
|
|
|
OPLL
|
[NCBI]
|
0.00011966
|
|
|
goodpasture syndrome
|
[NCBI]
|
0.00011966
|
|
|
IHH
|
[NCBI]
|
0.000118484
|
|
|
OSM
|
[NCBI]
|
0.00011798
|
|
|
COL19A1
|
[NCBI]
|
0.000111941
|
|
|
LOX
|
[NCBI]
|
0.000109855
|
|
|
AVSD
|
[NCBI]
|
0.000109323
|
|
|
PXE
|
[NCBI]
|
0.000107583
|
|
|
APC
|
[NCBI]
|
0.000106667
|
|
|
ACP5
|
[NCBI]
|
0.000106325
|
|
|
EBR1
|
[NCBI]
|
0.00010583
|
|
|
pulmonary fibrosis, idiopathic
|
[NCBI]
|
0.00010583
|
|
|
osteoarthritis
|
[NCBI]
|
0.00010583
|
|
|
NPS
|
[NCBI]
|
0.000101844
|
|
|
VIP
|
[NCBI]
|
0.000101449
|
|
|
FGF7
|
[NCBI]
|
0.000101147
|
|
|
COL6A2
|
[NCBI]
|
0.000100836
|
|
|
CBP2
|
[NCBI]
|
9.80218e-05
|
|
|
spondylometaphyseal dysplasia with dentinogenesis imperfecta
|
[NCBI]
|
9.76861e-05
|
|
|
cortical defects, wormian bones, and dentinogenesis imperfecta
|
[NCBI]
|
9.76861e-05
|
|
|
spondyloepimetaphyseal dysplasia, x-linked
|
[NCBI]
|
9.76861e-05
|
|
|
osteogenesis imperfecta, sillence type ii/iii, without abnormality of type i collagen
|
[NCBI]
|
9.76861e-05
|
|
|
spondyloepiphyseal dysplasia with punctate corneal dystrophy
|
[NCBI]
|
9.76861e-05
|
|
|
pachydermodactyly, familial
|
[NCBI]
|
9.76861e-05
|
|
|
dyssegmental dysplasia with glaucoma
|
[NCBI]
|
9.76861e-05
|
|
|
chondronectin
|
[NCBI]
|
9.76861e-05
|
|
|
keloids
|
[NCBI]
|
9.76861e-05
|
|
|
poikiloderma, hereditary sclerosing
|
[NCBI]
|
9.76861e-05
|
|
|
abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism
|
[NCBI]
|
9.76861e-05
|
|
|
platelet responsiveness to adrenaline, depressed
|
[NCBI]
|
9.76861e-05
|
|
|
baby rattle pelvis dysplasia
|
[NCBI]
|
9.76861e-05
|
|
|
spondyloperipheral dysplasia
|
[NCBI]
|
9.76861e-05
|
|
|
epiphyseal dysplasia, multiple, with myopia and conductive deafness
|
[NCBI]
|
9.76861e-05
|
|
|
COL9A2
|
[NCBI]
|
9.34532e-05
|
|
|
DDR1
|
[NCBI]
|
9.08717e-05
|
|
|
COL13A1
|
[NCBI]
|
8.77408e-05
|
|
|
DCN
|
[NCBI]
|
8.68603e-05
|
|
|
PPAC
|
[NCBI]
|
8.38856e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
8.36051e-05
|
|
|
LPL
|
[NCBI]
|
7.64414e-05
|
|
|
COL8A1
|
[NCBI]
|
7.58149e-05
|
|
|
ITGA2
|
[NCBI]
|
7.36823e-05
|
|
|
SRS
|
[NCBI]
|
7.25622e-05
|
|
|
paget disease, juvenile
|
[NCBI]
|
7.16779e-05
|
|
|
BDNF
|
[NCBI]
|
6.85297e-05
|
|
|
hypoascorbemia
|
[NCBI]
|
6.8337e-05
|
|
|
car factor deficiency
|
[NCBI]
|
6.64104e-05
|
|
|
glanzmann thrombasthenia, autosomal dominant
|
[NCBI]
|
6.64104e-05
|
|
|
fascial dystrophy, congenital
|
[NCBI]
|
6.64104e-05
|
|
|
phace association
|
[NCBI]
|
6.64104e-05
|
|
|
spondyloocular syndrome, autosomal recessive
|
[NCBI]
|
6.64104e-05
|
|
|
osteogenesis imperfecta, type vii
|
[NCBI]
|
6.64104e-05
|
|
|
WZS
|
[NCBI]
|
6.64104e-05
|
|
|
osteogenesis imperfecta, type viii
|
[NCBI]
|
6.64104e-05
|
|
|
epidermolysis bullosa with deficiency of galactosylhydroxylysyl glucosyltransferase
|
[NCBI]
|
6.64104e-05
|
|
|
spondyloepimetaphyseal dysplasia, type ii
|
[NCBI]
|
6.64104e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
6.46257e-05
|
|
|
CHS
|
[NCBI]
|
6.41271e-05
|
|
|
RP
|
[NCBI]
|
6.40911e-05
|
|
|
AR
|
[NCBI]
|
6.27298e-05
|
|
|
PLOD1
|
[NCBI]
|
6.15117e-05
|
|
|
TNC
|
[NCBI]
|
6.11756e-05
|
|
|
IGAN1
|
[NCBI]
|
5.87132e-05
|
|
|
diabetes insipidus, neurohypophyseal type
|
[NCBI]
|
5.7352e-05
|
|
|
KLK3
|
[NCBI]
|
5.63594e-05
|
|
|
PWS
|
[NCBI]
|
5.58514e-05
|
|
|
MBP
|
[NCBI]
|
5.51912e-05
|
|
|
EPO
|
[NCBI]
|
5.5142e-05
|
|
|
ATS
|
[NCBI]
|
5.48019e-05
|
|
|
LORD
|
[NCBI]
|
5.48019e-05
|
|
|
ehlers-danlos-like syndrome due to tenascin-x deficiency
|
[NCBI]
|
5.48019e-05
|
|
|
EDM5
|
[NCBI]
|
5.48019e-05
|
|
|
spondyloepiphyseal dysplasia, kimberley type
|
[NCBI]
|
5.48019e-05
|
|
|
CNA2
|
[NCBI]
|
5.48019e-05
|
|
|
cardiomyopathy, congestive, with hypergonadotropic hypogonadism
|
[NCBI]
|
5.48019e-05
|
|
|
buerger disease
|
[NCBI]
|
5.48019e-05
|
|
|
ehlers-danlos syndrome, type iii
|
[NCBI]
|
5.48019e-05
|
|
|
heterotopia, periventricular, ehlers-danlos variant
|
[NCBI]
|
5.48019e-05
|
|
|
menkes disease
|
[NCBI]
|
5.46328e-05
|
|
|
CJD
|
[NCBI]
|
5.16144e-05
|
|
|
CFTR
|
[NCBI]
|
5.09905e-05
|
|
|
CHAT
|
[NCBI]
|
5.06241e-05
|
|
|
COL12A1
|
[NCBI]
|
5.05411e-05
|
|
|
DHFR
|
[NCBI]
|
5.04051e-05
|
|
|
CEACAM5
|
[NCBI]
|
4.7614e-05
|
|
|
corneal dystrophy, epithelial basement membrane
|
[NCBI]
|
4.73738e-05
|
|
|
bleeding disorder due to p2ry12 defect
|
[NCBI]
|
4.73738e-05
|
|
|
DFNA13
|
[NCBI]
|
4.73738e-05
|
|
|
cutis laxa, x-linked
|
[NCBI]
|
4.71659e-05
|
|
|
MMP2
|
[NCBI]
|
4.50701e-05
|
|
|
HPS
|
[NCBI]
|
4.50142e-05
|
|
|
NGFB
|
[NCBI]
|
4.48953e-05
|
|
|
EDM4
|
[NCBI]
|
4.19313e-05
|
|
|
ACG1B
|
[NCBI]
|
4.19313e-05
|
|
|
hydroxyprolinemia
|
[NCBI]
|
4.19313e-05
|
|
|
IDD
|
[NCBI]
|
4.19313e-05
|
|
|
FMOD
|
[NCBI]
|
4.16835e-05
|
|
|
HGPS
|
[NCBI]
|
4.13982e-05
|
|
|
P4HA3
|
[NCBI]
|
4.03636e-05
|
|
|
GP6
|
[NCBI]
|
4.03636e-05
|
|
|
COL16A1
|
[NCBI]
|
4.03636e-05
|
|
|
COL25A1
|
[NCBI]
|
4.03636e-05
|
|
|
COL4A3BP
|
[NCBI]
|
4.03636e-05
|
|
|
MMP14
|
[NCBI]
|
4.01113e-05
|
|
|
EGFR
|
[NCBI]
|
4.01032e-05
|
|
|
ACH
|
[NCBI]
|
3.96493e-05
|
|
|
MMP1
|
[NCBI]
|
3.9255e-05
|
|
|
fibromatosis, juvenile hyaline
|
[NCBI]
|
3.76581e-05
|
|
|
winchester syndrome
|
[NCBI]
|
3.76581e-05
|
|
|
CAT
|
[NCBI]
|
3.6796e-05
|
|
|
AFP
|
[NCBI]
|
3.65563e-05
|
|
|
giant platelet syndrome
|
[NCBI]
|
3.54147e-05
|
|
|
kindler syndrome
|
[NCBI]
|
3.41577e-05
|
|
|
FDH
|
[NCBI]
|
3.41577e-05
|
|
|
epiphyseal dysplasia, multiple, with early-onset diabetes mellitus
|
[NCBI]
|
3.41577e-05
|
|
|
aortic valve disease
|
[NCBI]
|
3.41577e-05
|
|
|
G6PD
|
[NCBI]
|
3.40191e-05
|
|
|
FCN1
|
[NCBI]
|
3.26653e-05
|
|
|
ITGA1
|
[NCBI]
|
3.26653e-05
|
|
|
ADIPOQ
|
[NCBI]
|
3.16998e-05
|
|
|
hyperostosis corticalis generalisata
|
[NCBI]
|
3.12064e-05
|
|
|
WGN1
|
[NCBI]
|
3.12064e-05
|
|
|
tibial muscular dystrophy, tardive
|
[NCBI]
|
3.12064e-05
|
|
|
OPPG
|
[NCBI]
|
3.12064e-05
|
|
|
SEMA3A
|
[NCBI]
|
3.07747e-05
|
|
|
ZBTB7B
|
[NCBI]
|
3.0282e-05
|
|
|
FCMD
|
[NCBI]
|
3.00915e-05
|
|
|
APOE
|
[NCBI]
|
2.93075e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
2.91911e-05
|
|
|
FOP
|
[NCBI]
|
2.91224e-05
|
|
|
ITGB1
|
[NCBI]
|
2.90837e-05
|
|
|
MNS
|
[NCBI]
|
2.86658e-05
|
|
|
SCDO1
|
[NCBI]
|
2.86658e-05
|
|
|
HSAN2
|
[NCBI]
|
2.86658e-05
|
|
|
CCL7
|
[NCBI]
|
2.83551e-05
|
|
|
LUM
|
[NCBI]
|
2.83551e-05
|
|
|
ILK
|
[NCBI]
|
2.68782e-05
|
|
|
LEPRE1
|
[NCBI]
|
2.67388e-05
|
|
|
osteoporosis, juvenile
|
[NCBI]
|
2.64439e-05
|
|
|
ADA
|
[NCBI]
|
2.5409e-05
|
|
|
COL23A1
|
[NCBI]
|
2.52694e-05
|
|
|
collagen, type xii, alpha 1-like
|
[NCBI]
|
2.52694e-05
|
|
|
EPN3
|
[NCBI]
|
2.52694e-05
|
|
|
ITGA10
|
[NCBI]
|
2.52694e-05
|
|
|
junctional adhesion molecule 4
|
[NCBI]
|
2.52694e-05
|
|
|
COL28A1
|
[NCBI]
|
2.52694e-05
|
|
|
RBMS3
|
[NCBI]
|
2.52694e-05
|
|
|
COL24A1
|
[NCBI]
|
2.52694e-05
|
|
|
COL5A3
|
[NCBI]
|
2.52694e-05
|
|
|
CCDC2
|
[NCBI]
|
2.52694e-05
|
|
|
REM1
|
[NCBI]
|
2.52694e-05
|
|
|
COL22A1
|
[NCBI]
|
2.52694e-05
|
|
|
COL1AR
|
[NCBI]
|
2.52694e-05
|
|
|
SVAS
|
[NCBI]
|
2.47695e-05
|
|
|
THC2
|
[NCBI]
|
2.44767e-05
|
|
|
EDM1
|
[NCBI]
|
2.44767e-05
|
|
|
PALS
|
[NCBI]
|
2.44767e-05
|
|
|
FTNS
|
[NCBI]
|
2.44767e-05
|
|
|
apert syndrome
|
[NCBI]
|
2.44767e-05
|
|
|
BMND1
|
[NCBI]
|
2.44767e-05
|
|
|
PDGFB
|
[NCBI]
|
2.43793e-05
|
|
|
APCS
|
[NCBI]
|
2.41439e-05
|
|
|
IL1B
|
[NCBI]
|
2.38913e-05
|
|
|
SHBG
|
[NCBI]
|
2.34058e-05
|
|
|
WARS
|
[NCBI]
|
2.3044e-05
|
|
|
C1QA
|
[NCBI]
|
2.3044e-05
|
|
|
aspirin resistance
|
[NCBI]
|
2.27176e-05
|
|
|
epidermolysis bullosa simplex and limb-girdle muscular dystrophy
|
[NCBI]
|
2.27176e-05
|
|
|
pseudoxanthoma elasticum, forme fruste
|
[NCBI]
|
2.27176e-05
|
|
|
EFE
|
[NCBI]
|
2.27176e-05
|
|
|
ichthyosis congenita, harlequin fetus type
|
[NCBI]
|
2.27176e-05
|
|
|
EPS
|
[NCBI]
|
2.27176e-05
|
|
|
KTCN1
|
[NCBI]
|
2.27176e-05
|
|
|
GDF5
|
[NCBI]
|
2.16907e-05
|
|
|
VASP
|
[NCBI]
|
2.15493e-05
|
|
|
sulfocysteinuria
|
[NCBI]
|
2.11317e-05
|
|
|
TGFB1
|
[NCBI]
|
2.08715e-05
|
|
|
AT
|
[NCBI]
|
2.05821e-05
|
|
|
ADCYAP1
|
[NCBI]
|
2.04272e-05
|
|
|
BGN
|
[NCBI]
|
2.01664e-05
|
|
|
IL13
|
[NCBI]
|
2.01664e-05
|
|
|
RNASE3
|
[NCBI]
|
2.00997e-05
|
|
|
AHR
|
[NCBI]
|
2.00626e-05
|
|
|
SHH
|
[NCBI]
|
1.94709e-05
|
|
|
LAM
|
[NCBI]
|
1.94591e-05
|
|
|
PEPD
|
[NCBI]
|
1.8808e-05
|
|
|
THBS1
|
[NCBI]
|
1.82873e-05
|
|
|
C5ORF13
|
[NCBI]
|
1.78939e-05
|
|
|
LEPREL1
|
[NCBI]
|
1.78939e-05
|
|
|
IL20
|
[NCBI]
|
1.78939e-05
|
|
|
EMID2
|
[NCBI]
|
1.78939e-05
|
|
|
NID2
|
[NCBI]
|
1.78939e-05
|
|
|
AP3M2
|
[NCBI]
|
1.78939e-05
|
|
|
FCN2
|
[NCBI]
|
1.78939e-05
|
|
|
MIRN192
|
[NCBI]
|
1.78939e-05
|
|
|
ITGA11
|
[NCBI]
|
1.78939e-05
|
|
|
SVEP1
|
[NCBI]
|
1.78939e-05
|
|
|
TFPI
|
[NCBI]
|
1.78661e-05
|
|
|
FSHMD1A
|
[NCBI]
|
1.78542e-05
|
|
|
myasthenic syndrome, congenital, associated with episodic apnea
|
[NCBI]
|
1.71738e-05
|
|
|
CNC1
|
[NCBI]
|
1.71738e-05
|
|
|
TNFSF6
|
[NCBI]
|
1.68455e-05
|
|
|
CD47
|
[NCBI]
|
1.67459e-05
|
|
|
XDH
|
[NCBI]
|
1.62388e-05
|
|
|
LAMB3
|
[NCBI]
|
1.60869e-05
|
|
|
BMP1
|
[NCBI]
|
1.60869e-05
|
|
|
mucolipidosis iiia
|
[NCBI]
|
1.60641e-05
|
|
|
epidermolysis bullosa with pyloric atresia
|
[NCBI]
|
1.60641e-05
|
|
|
NPPA
|
[NCBI]
|
1.59084e-05
|
|
|
FGF1
|
[NCBI]
|
1.57608e-05
|
|
|
IL2
|
[NCBI]
|
1.53906e-05
|
|
|
TNXB
|
[NCBI]
|
1.51613e-05
|
|
|
DDAH2
|
[NCBI]
|
1.514e-05
|
|
|
ERBB2IP
|
[NCBI]
|
1.514e-05
|
|
|
PDLIM2
|
[NCBI]
|
1.514e-05
|
|
|
LEPREL2
|
[NCBI]
|
1.514e-05
|
|
|
ADAMTS14
|
[NCBI]
|
1.514e-05
|
|
|
QSCN6
|
[NCBI]
|
1.514e-05
|
|
|
DLX1
|
[NCBI]
|
1.514e-05
|
|
|
COL21A1
|
[NCBI]
|
1.514e-05
|
|
|
COL8A2
|
[NCBI]
|
1.514e-05
|
|
|
complement factor h deficiency
|
[NCBI]
|
1.50382e-05
|
|
|
epidermolysis bullosa letalis
|
[NCBI]
|
1.50382e-05
|
|
|
TLR4
|
[NCBI]
|
1.4878e-05
|
|
|
BL
|
[NCBI]
|
1.42971e-05
|
|
|
MMP9
|
[NCBI]
|
1.41069e-05
|
|
|
MHA
|
[NCBI]
|
1.4087e-05
|
|
|
UCMD
|
[NCBI]
|
1.4087e-05
|
|
|
factor xii deficiency
|
[NCBI]
|
1.4087e-05
|
|
|
TNF
|
[NCBI]
|
1.37607e-05
|
|
|
COLEC12
|
[NCBI]
|
1.33684e-05
|
|
|
ZNF185
|
[NCBI]
|
1.33684e-05
|
|
|
MIRN34A
|
[NCBI]
|
1.33684e-05
|
|
|
P4HA2
|
[NCBI]
|
1.33684e-05
|
|
|
SYVN1
|
[NCBI]
|
1.33684e-05
|
|
|
UNC5B
|
[NCBI]
|
1.33684e-05
|
|
|
CREB3L2
|
[NCBI]
|
1.33684e-05
|
|
|
C1QTNF5
|
[NCBI]
|
1.33684e-05
|
|
|
GPC1
|
[NCBI]
|
1.33684e-05
|
|
|
SEC23A
|
[NCBI]
|
1.33684e-05
|
|
|
MEP1B
|
[NCBI]
|
1.33684e-05
|
|
|
DFNB1
|
[NCBI]
|
1.32025e-05
|
|
|
TF
|
[NCBI]
|
1.2307e-05
|
|
|
HLA-DQA1
|
[NCBI]
|
1.22217e-05
|
|
|
MB
|
[NCBI]
|
1.2125e-05
|
|
|
DPT
|
[NCBI]
|
1.20633e-05
|
|
|
PLOD2
|
[NCBI]
|
1.20633e-05
|
|
|
LAMA4
|
[NCBI]
|
1.20633e-05
|
|
|
CTPS
|
[NCBI]
|
1.20633e-05
|
|
|
OPTC
|
[NCBI]
|
1.20633e-05
|
|
|
BTG1
|
[NCBI]
|
1.20633e-05
|
|
|
GPC4
|
[NCBI]
|
1.20633e-05
|
|
|
CHAD
|
[NCBI]
|
1.20633e-05
|
|
|
KLF15
|
[NCBI]
|
1.20633e-05
|
|
|
VDR
|
[NCBI]
|
1.19e-05
|
|
|
campomelic dysplasia
|
[NCBI]
|
1.16079e-05
|
|
|
ARRB1
|
[NCBI]
|
1.10331e-05
|
|
|
ZNF384
|
[NCBI]
|
1.10331e-05
|
|
|
MFRP
|
[NCBI]
|
1.10331e-05
|
|
|
PLOD3
|
[NCBI]
|
1.10331e-05
|
|
|
GNA13
|
[NCBI]
|
1.10331e-05
|
|
|
LAIR1
|
[NCBI]
|
1.10331e-05
|
|
|
SOX5
|
[NCBI]
|
1.10331e-05
|
|
|
CRTAP
|
[NCBI]
|
1.10331e-05
|
|
|
CTSH
|
[NCBI]
|
1.10331e-05
|
|
|
LECT1
|
[NCBI]
|
1.10331e-05
|
|
|
C1QG
|
[NCBI]
|
1.10331e-05
|
|
|
MMP10
|
[NCBI]
|
1.10331e-05
|
|
|
SLC22A4
|
[NCBI]
|
1.10331e-05
|
|
|
GCPS
|
[NCBI]
|
1.08872e-05
|
|
|
TTP
|
[NCBI]
|
1.02115e-05
|
|
|
HFTC
|
[NCBI]
|
1.02115e-05
|
|
|
THBS2
|
[NCBI]
|
1.01844e-05
|
|
|
DPYSL2
|
[NCBI]
|
1.01844e-05
|
|
|
WISP3
|
[NCBI]
|
1.01844e-05
|
|
|
LCP2
|
[NCBI]
|
1.01844e-05
|
|
|
SOX6
|
[NCBI]
|
1.01844e-05
|
|
|
DLX2
|
[NCBI]
|
1.01844e-05
|
|
|
P4HA1
|
[NCBI]
|
1.01844e-05
|
|
|
SORL1
|
[NCBI]
|
1.01844e-05
|
|
|
EMILIN1
|
[NCBI]
|
1.01844e-05
|
|
|
P2RY12
|
[NCBI]
|
1.01844e-05
|
|
|
DMP1
|
[NCBI]
|
1.01844e-05
|
|
|
ITM2A
|
[NCBI]
|
1.01844e-05
|
|
|
TCF8
|
[NCBI]
|
1.01844e-05
|
|
|
C1QB
|
[NCBI]
|
1.01844e-05
|
|
|
FN1
|
[NCBI]
|
1.00732e-05
|
|
|
WAS
|
[NCBI]
|
9.86583e-06
|
|
|
FGF10
|
[NCBI]
|
9.84289e-06
|
|
|
SOX9
|
[NCBI]
|
9.61967e-06
|
|
|
HOXD3
|
[NCBI]
|
9.46478e-06
|
|
|
TTK
|
[NCBI]
|
9.46478e-06
|
|
|
MMRN1
|
[NCBI]
|
9.46478e-06
|
|
|
AUH
|
[NCBI]
|
9.46478e-06
|
|
|
S100A7
|
[NCBI]
|
9.46478e-06
|
|
|
SPRY1
|
[NCBI]
|
9.46478e-06
|
|
|
SLC31A1
|
[NCBI]
|
9.46478e-06
|
|
|
MPO
|
[NCBI]
|
9.36679e-06
|
|
|
CNTF
|
[NCBI]
|
9.20051e-06
|
|
|
TTR
|
[NCBI]
|
8.99992e-06
|
|
|
RAP1B
|
[NCBI]
|
8.84166e-06
|
|
|
ANTXR2
|
[NCBI]
|
8.84166e-06
|
|
|
SCGB3A2
|
[NCBI]
|
8.84166e-06
|
|
|
VEGFB
|
[NCBI]
|
8.84166e-06
|
|
|
MMP3
|
[NCBI]
|
8.79065e-06
|
|
|
COMT
|
[NCBI]
|
8.34919e-06
|
|
|
CYR61
|
[NCBI]
|
8.29343e-06
|
|
|
KERA
|
[NCBI]
|
8.29343e-06
|
|
|
AGC1
|
[NCBI]
|
8.29343e-06
|
|
|
CCL11
|
[NCBI]
|
8.29343e-06
|
|
|
TNFSF13
|
[NCBI]
|
8.29343e-06
|
|
|
SPDA1
|
[NCBI]
|
7.89092e-06
|
|
|
CXCL10
|
[NCBI]
|
7.80504e-06
|
|
|
VIL
|
[NCBI]
|
7.80504e-06
|
|
|
PECAM1
|
[NCBI]
|
7.80504e-06
|
|
|
PLEC1
|
[NCBI]
|
7.80504e-06
|
|
|
AKT1
|
[NCBI]
|
7.54515e-06
|
|
|
ENPP2
|
[NCBI]
|
7.54515e-06
|
|
|
bartter syndrome, type 3
|
[NCBI]
|
7.39235e-06
|
|
|
PLA2G4A
|
[NCBI]
|
7.36556e-06
|
|
|
CD82
|
[NCBI]
|
7.36556e-06
|
|
|
PFN1
|
[NCBI]
|
7.36556e-06
|
|
|
SEPT5
|
[NCBI]
|
7.36556e-06
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
7.11933e-06
|
|
|
MATN3
|
[NCBI]
|
6.96679e-06
|
|
|
RECK
|
[NCBI]
|
6.96679e-06
|
|
|
ASCL1
|
[NCBI]
|
6.96679e-06
|
|
|
CILP
|
[NCBI]
|
6.96679e-06
|
|
|
GALNT3
|
[NCBI]
|
6.96679e-06
|
|
|
AEBP1
|
[NCBI]
|
6.96679e-06
|
|
|
OGN
|
[NCBI]
|
6.96679e-06
|
|
|
PAPSS2
|
[NCBI]
|
6.96679e-06
|
|
|
RLBP1
|
[NCBI]
|
6.64172e-06
|
|
|
SEMA3F
|
[NCBI]
|
6.60247e-06
|
|
|
IDH1
|
[NCBI]
|
6.60247e-06
|
|
|
ANXA2
|
[NCBI]
|
6.60247e-06
|
|
|
PLAG1
|
[NCBI]
|
6.60247e-06
|
|
|
NOV
|
[NCBI]
|
6.60247e-06
|
|
|
PRDX5
|
[NCBI]
|
6.60247e-06
|
|
|
GDNF
|
[NCBI]
|
6.41655e-06
|
|
|
DMD
|
[NCBI]
|
6.40191e-06
|
|
|
TBXA2R
|
[NCBI]
|
6.26765e-06
|
|
|
HTATIP
|
[NCBI]
|
6.26765e-06
|
|
|
INS
|
[NCBI]
|
6.18057e-06
|
|
|
TNFSF11
|
[NCBI]
|
6.1308e-06
|
|
|
ELN
|
[NCBI]
|
6.10723e-06
|
|
|
TD1
|
[NCBI]
|
6.05787e-06
|
|
|
CNP
|
[NCBI]
|
5.95838e-06
|
|
|
PRKCA
|
[NCBI]
|
5.95838e-06
|
|
|
ZEB2
|
[NCBI]
|
5.95838e-06
|
|
|
MMP13
|
[NCBI]
|
5.95838e-06
|
|
|
FOS
|
[NCBI]
|
5.95838e-06
|
|
|
METAP2
|
[NCBI]
|
5.95838e-06
|
|
|
SLC26A2
|
[NCBI]
|
5.95838e-06
|
|
|
SEMA4D
|
[NCBI]
|
5.95838e-06
|
|
|
PMCH
|
[NCBI]
|
5.94489e-06
|
|
|
GRB2
|
[NCBI]
|
5.73698e-06
|
|
|
GPI
|
[NCBI]
|
5.57849e-06
|
|
|
RASA1
|
[NCBI]
|
5.57849e-06
|
|
|
CDH2
|
[NCBI]
|
5.4043e-06
|
|
|
CAMP
|
[NCBI]
|
5.4043e-06
|
|
|
SPG7
|
[NCBI]
|
5.15465e-06
|
|
|
ANGPT2
|
[NCBI]
|
5.15465e-06
|
|
|
FGB
|
[NCBI]
|
5.15465e-06
|
|
|
LMX1B
|
[NCBI]
|
4.92069e-06
|
|
|
PHB
|
[NCBI]
|
4.92069e-06
|
|
|
TNFRSF13B
|
[NCBI]
|
4.92069e-06
|
|
|
CEBPB
|
[NCBI]
|
4.92069e-06
|
|
|
DSPP
|
[NCBI]
|
4.85936e-06
|
|
|
IAPP
|
[NCBI]
|
4.7972e-06
|
|
|
EEA1
|
[NCBI]
|
4.70083e-06
|
|
|
NEB
|
[NCBI]
|
4.70083e-06
|
|
|
PPARD
|
[NCBI]
|
4.70083e-06
|
|
|
ACE
|
[NCBI]
|
4.68668e-06
|
|
|
HHT
|
[NCBI]
|
4.59545e-06
|
|
|
CYGB
|
[NCBI]
|
4.49374e-06
|
|
|
FUS
|
[NCBI]
|
4.49374e-06
|
|
|
MYH9
|
[NCBI]
|
4.49374e-06
|
|
|
CD36
|
[NCBI]
|
4.47223e-06
|
|
|
ALB
|
[NCBI]
|
4.35793e-06
|
|
|
EIF5A
|
[NCBI]
|
4.29825e-06
|
|
|
F12
|
[NCBI]
|
4.29825e-06
|
|
|
EDA
|
[NCBI]
|
4.29825e-06
|
|
|
WBS
|
[NCBI]
|
4.19349e-06
|
|
|
NTN1
|
[NCBI]
|
4.11335e-06
|
|
|
DSP
|
[NCBI]
|
4.11335e-06
|
|
|
PDGFRB
|
[NCBI]
|
4.11335e-06
|
|
|
PGR
|
[NCBI]
|
4.05887e-06
|
|
|
TRAF6
|
[NCBI]
|
3.93817e-06
|
|
|
AMH
|
[NCBI]
|
3.86035e-06
|
|
|
ADAMTS13
|
[NCBI]
|
3.77191e-06
|
|
|
IL1RN
|
[NCBI]
|
3.77191e-06
|
|
|
SRF
|
[NCBI]
|
3.75501e-06
|
|
|
SERPINA6
|
[NCBI]
|
3.73919e-06
|
|
|
SLPI
|
[NCBI]
|
3.65853e-06
|
|
|
MTND2
|
[NCBI]
|
3.6139e-06
|
|
|
LTC4S
|
[NCBI]
|
3.6139e-06
|
|
|
FGF2
|
[NCBI]
|
3.49744e-06
|
|
|
ALCAM
|
[NCBI]
|
3.46353e-06
|
|
|
DAG1
|
[NCBI]
|
3.46353e-06
|
|
|
UGB
|
[NCBI]
|
3.40492e-06
|
|
|
SOD1
|
[NCBI]
|
3.38156e-06
|
|
|
APRT
|
[NCBI]
|
3.38156e-06
|
|
|
BSG
|
[NCBI]
|
3.33324e-06
|
|
|
STC1
|
[NCBI]
|
3.33324e-06
|
|
|
GHR
|
[NCBI]
|
3.32285e-06
|
|
|
GLI3
|
[NCBI]
|
3.32024e-06
|
|
|
ELA2
|
[NCBI]
|
3.32024e-06
|
|
|
NGFR
|
[NCBI]
|
3.19211e-06
|
|
|
PPIB
|
[NCBI]
|
3.18356e-06
|
|
|
AQP5
|
[NCBI]
|
3.18356e-06
|
|
|
LAT
|
[NCBI]
|
3.12604e-06
|
|
|
ALDH1A2
|
[NCBI]
|
3.05303e-06
|
|
|
DHH
|
[NCBI]
|
3.05303e-06
|
|
|
TLR2
|
[NCBI]
|
2.80674e-06
|
|
|
FTL
|
[NCBI]
|
2.6946e-06
|
|
|
HPX
|
[NCBI]
|
2.6946e-06
|
|
|
ACPP
|
[NCBI]
|
2.59284e-06
|
|
|
CYP11B2
|
[NCBI]
|
2.58508e-06
|
|
|
CP
|
[NCBI]
|
2.57057e-06
|
|
|
TP53
|
[NCBI]
|
2.53032e-06
|
|
|
F3
|
[NCBI]
|
2.46485e-06
|
|
|
CREM
|
[NCBI]
|
2.3793e-06
|
|
|
CXCL12
|
[NCBI]
|
2.3793e-06
|
|
|
POU1F1
|
[NCBI]
|
2.3793e-06
|
|
|
TIMP1
|
[NCBI]
|
2.3793e-06
|
|
|
ADORA3
|
[NCBI]
|
2.3793e-06
|
|
|
PCNA
|
[NCBI]
|
2.32555e-06
|
|
|
RUNX2
|
[NCBI]
|
2.28256e-06
|
|
|
ACCN2
|
[NCBI]
|
2.28256e-06
|
|
|
IL8
|
[NCBI]
|
2.18963e-06
|
|
|
PDE6B
|
[NCBI]
|
2.18963e-06
|
|
|
JAG1
|
[NCBI]
|
2.10031e-06
|
|
|
TNFSF13B
|
[NCBI]
|
2.01443e-06
|
|
|
INHBA
|
[NCBI]
|
2.01443e-06
|
|
|
MAPK1
|
[NCBI]
|
1.95335e-06
|
|
|
CYP3A4
|
[NCBI]
|
1.93181e-06
|
|
|
LIFR
|
[NCBI]
|
1.93181e-06
|
|
|
STAT3
|
[NCBI]
|
1.79292e-06
|
|
|
CCD
|
[NCBI]
|
1.74576e-06
|
|
|
MUC1
|
[NCBI]
|
1.71904e-06
|
|
|
ARF6
|
[NCBI]
|
1.70206e-06
|
|
|
DES
|
[NCBI]
|
1.63105e-06
|
|
|
RUNX1
|
[NCBI]
|
1.63105e-06
|
|
|
VIM
|
[NCBI]
|
1.61095e-06
|
|
|
GJA1
|
[NCBI]
|
1.54317e-06
|
|
|
CSF2
|
[NCBI]
|
1.4967e-06
|
|
|
PTHLH
|
[NCBI]
|
1.35429e-06
|
|
|
PTN
|
[NCBI]
|
1.34942e-06
|
|
|
ABCA1
|
[NCBI]
|
1.25575e-06
|
|
|
MYH7
|
[NCBI]
|
1.25575e-06
|
|
|
HS
|
[NCBI]
|
1.25575e-06
|
|
|
FLNA
|
[NCBI]
|
1.20077e-06
|
|
|
protoporphyria, erythropoietic
|
[NCBI]
|
1.20077e-06
|
|
|
JAK2
|
[NCBI]
|
1.17307e-06
|
|
|
HDC
|
[NCBI]
|
1.16894e-06
|
|
|
GAPDH
|
[NCBI]
|
1.15168e-06
|
|
|
WT1
|
[NCBI]
|
1.09657e-06
|
|
|
PEDF
|
[NCBI]
|
1.07882e-06
|
|
|
DMD
|
[NCBI]
|
1.04777e-06
|
|
|
MAS
|
[NCBI]
|
9.83432e-07
|
|
|
polycystic kidneys
|
[NCBI]
|
9.44623e-07
|
|
|
wilson disease
|
[NCBI]
|
9.07502e-07
|
|
|
PPARA
|
[NCBI]
|
8.95256e-07
|
|
|
CFB
|
[NCBI]
|
8.66563e-07
|
|
|
UMOD
|
[NCBI]
|
8.66563e-07
|
|
|
MHS1
|
[NCBI]
|
8.22062e-07
|
|
|
ACHE
|
[NCBI]
|
7.47453e-07
|
|
|
CEL
|
[NCBI]
|
7.10176e-07
|
|
|
DSG3
|
[NCBI]
|
5.75084e-07
|
|
|
ENPEP
|
[NCBI]
|
5.75084e-07
|
|
|
ITGB3
|
[NCBI]
|
5.75084e-07
|
|
|
MBL2
|
[NCBI]
|
5.69971e-07
|
|
|
IGFALS
|
[NCBI]
|
5.69684e-07
|
|
|
CTNNB1
|
[NCBI]
|
5.1474e-07
|
|
|
LEP
|
[NCBI]
|
5.12252e-07
|
|
|
TG
|
[NCBI]
|
5.01927e-07
|
|
|
FGFR2
|
[NCBI]
|
4.94023e-07
|
|
|
GFAP
|
[NCBI]
|
4.86758e-07
|
|
|
PSORS1
|
[NCBI]
|
4.70486e-07
|
|
|
BCHE
|
[NCBI]
|
4.48256e-07
|
|
|
TERT
|
[NCBI]
|
4.08418e-07
|
|
|
LCN2
|
[NCBI]
|
3.82763e-07
|
|
|
PF4
|
[NCBI]
|
3.21375e-07
|
|
|
ANG
|
[NCBI]
|
3.15386e-07
|
|
|
STAT5A
|
[NCBI]
|
3.05018e-07
|
|
|
KDR
|
[NCBI]
|
2.91994e-07
|
|
|
AGER
|
[NCBI]
|
2.91335e-07
|
|
|
JMML
|
[NCBI]
|
2.77714e-07
|
|
|
WT1
|
[NCBI]
|
2.77714e-07
|
|
|
OCP
|
[NCBI]
|
2.77714e-07
|
|
|
MAG
|
[NCBI]
|
2.67711e-07
|
|
|
PTEN
|
[NCBI]
|
2.66639e-07
|
|
|
CCL2
|
[NCBI]
|
2.5604e-07
|
|
|
CDK2
|
[NCBI]
|
2.52331e-07
|
|
|
FRAP1
|
[NCBI]
|
2.17875e-07
|
|
|
CPI
|
[NCBI]
|
2.12887e-07
|
|
|
TBP
|
[NCBI]
|
1.85522e-07
|
|
|
CMH
|
[NCBI]
|
1.79706e-07
|
|
|
IL6
|
[NCBI]
|
1.76276e-07
|
|
|
LPI
|
[NCBI]
|
1.75055e-07
|
|
|
MAP3K5
|
[NCBI]
|
1.74947e-07
|
|
|
UCN
|
[NCBI]
|
1.64635e-07
|
|
|
asthma, susceptibility to
|
[NCBI]
|
1.3928e-07
|
|
|
HFE
|
[NCBI]
|
1.39219e-07
|
|
|
FGFR3
|
[NCBI]
|
1.32671e-07
|
|
|
PLAUR
|
[NCBI]
|
1.26105e-07
|
|
|
STAT6
|
[NCBI]
|
1.2062e-07
|
|
|
von willebrand disease
|
[NCBI]
|
1.17171e-07
|
|
|
PLG
|
[NCBI]
|
1.12895e-07
|
|
|
HLA-A
|
[NCBI]
|
9.82989e-08
|
|
|
RNASE2
|
[NCBI]
|
9.21114e-08
|
|
|
WRN
|
[NCBI]
|
7.47117e-08
|
|
|
PPIA
|
[NCBI]
|
6.29303e-08
|
|
|
AQP1
|
[NCBI]
|
6.12286e-08
|
|
|
TNFSF10
|
[NCBI]
|
5.56603e-08
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
5.02376e-08
|
|
|
CLU
|
[NCBI]
|
4.62691e-08
|
|
|
CFH
|
[NCBI]
|
4.43832e-08
|
|
|
CCL22
|
[NCBI]
|
3.96405e-08
|
|
|
PRKCM
|
[NCBI]
|
2.43678e-08
|
|
|
LRP1
|
[NCBI]
|
1.99317e-08
|
|
|
BMP4
|
[NCBI]
|
1.64798e-08
|
|
|
PPARG
|
[NCBI]
|
1.0068e-08
|
|
|
GUSB
|
[NCBI]
|
8.32431e-10
|
|
|
homocystinuria
|
[NCBI]
|
8.32431e-10
|
|
|
PKD1
|
[NCBI]
|
2.04615e-10
|
|
|
ASS
|
[NCBI]
|
1.08419e-13
|
|
|
CPB2
|
[NCBI]
|
1.08419e-13
|
|